QAELUM

QAELUM QAELUM - patient radiation dose management Qaelum is a high-tech spin-off company of both the University of Leuven and of the University Hospitals of Leuven.

Based upon more than 15 years of quality assurance experience in an academic environment as well as in the field, we are the preferred partner when it comes to medical imaging quality control.

Passionate about solving real world problems, we focus on the development and deployment of highly innovative solutions to overcome the everyday problems of every medical imaging professional. Ranging from automated quality control in nationwide breast screening programs to optimized solutions for local patient dose monitoring, management and optimization, we have solutions for all of your problems, no matter what scale they have.

Join us for a closer look at quality assurance in mammography and CT.In our upcoming webinar, Elizabeth Keavey will shar...
03/11/2026

Join us for a closer look at quality assurance in mammography and CT.

In our upcoming webinar, Elizabeth Keavey will share examples of remote quality monitoring and dosimetry in breast screening, while Hannah Renshall will discuss clinical audits using Qaelum DOSE in CT.

Hear practical approaches to optimisation and training, then bring your questions to the live Q&A.

17 November 2026 · 15:00–16:00 CET
Online via Zoom

Read more and register: https://qaelum.com/events/upcoming-events/webinar-from-monitoring-to-action-quality-assurance-in-mammography-and-ct

📊 Diagnostic Reference Levels (DRLs): A Tool for Optimization, Not a Dose LimitDiagnostic Reference Levels (DRLs) play a...
27/10/2026

📊 Diagnostic Reference Levels (DRLs): A Tool for Optimization, Not a Dose Limit

Diagnostic Reference Levels (DRLs) play an important role in supporting safe and effective medical imaging—but they're often misunderstood.

DRLs are optimization tools, not regulatory dose limits. They help imaging departments identify examinations with unusually high radiation doses and highlight opportunities to improve protocols and clinical practice.

Why it matters:

✔ Support dose optimization
✔ Benchmark clinical practice
✔ Strengthen quality assurance
✔ Promote continuous improvement across scanners and facilities

With the right insights, DRL monitoring becomes more than a compliance exercise—it becomes a foundation for data-driven quality improvement.

Learn how DOSE by Qaelum simplifies DRL monitoring, benchmarking, and compliance:

🔗 https://qaelum.com/solutions/dose

Qaelum | Transforming imaging data into actionable insights.

22/10/2026

Facebook

Different scanners. Different sites. A shared need to understand radiation exposure.

DOSE by Qaelum brings dose information into a common view to support monitoring, evaluation, and reporting.

Learn more about DOSE: https://qaelum.com/solutions/dose

What sits behind an unusual CT dose value?A clinical project featured in Qaelum’s article explored positioning, scan set...
20/10/2026

What sits behind an unusual CT dose value?

A clinical project featured in Qaelum’s article explored positioning, scan settings, and data completeness. It also highlighted the importance of checking image quality in low-dose outliers.

Read the article: https://qaelum.com/news/news/defining-ct-dose-optimization-targets-in-clinical-practice

A clinical study at Ortenau-Klinikum demonstrated how implementing IAEA dose optimization targets with Qaelum’s DOSE system enables consistent CT dose monitoring, identification of outliers, and actionable workflow improvements to enhance patient safety and imaging quality.

15/10/2026

What does a diagnostic reference level tell us?

DRLs help imaging teams review typical exposure levels for comparable examinations. They are not individual patient dose limits.

The numbers need to be considered alongside image quality and the examination’s purpose.

How does your team use DRLs in practice?

Behind every breast cancer diagnosis is a person, a family and a circle of people who care.On Breast Cancer Awareness Da...
13/10/2026

Behind every breast cancer diagnosis is a person, a family and a circle of people who care.

On Breast Cancer Awareness Day, we stand with everyone affected and recognise the healthcare teams supporting them.

At Qaelum, patient safety and imaging quality are central to our work. Today is a reminder of why that work matters.

Let’s share trusted information, listen with compassion and support access to timely diagnosis and quality care.

Seeing a pattern in imaging data is a starting point.The next step is a team conversation: what might explain it, what s...
08/10/2026

Seeing a pattern in imaging data is a starting point.

The next step is a team conversation: what might explain it, what should we review, and who will follow up?

A clear action and a planned review can help keep the discussion moving.

What works well in your department?

🕊️ Happy International Day of Non-Violence!A kinder world starts with how we treat one another.At Qaelum, we believe eve...
02/10/2026

🕊️ Happy International Day of Non-Violence!

A kinder world starts with how we treat one another.
At Qaelum, we believe everyone deserves to feel safe, respected and heard—in healthcare, in the workplace and beyond.

Let’s choose dialogue, resolve differences peacefully and show compassion in our everyday interactions.

Choose kindness. Act with respect. Today and every day. 🧡

💡 How should we communicate risk in medical imaging?Radiation risk is an important consideration in medical imaging—but ...
29/09/2026

💡 How should we communicate risk in medical imaging?
Radiation risk is an important consideration in medical imaging—but it is only one part of the overall risk-benefit picture.

In our article by Anna Romanyukha, PhD, and Niki Fitousi, PhD, explore current approaches to risk assessment and communication, including:

🔹 Clinical risk vs. radiation risk — why risk assessment should consider both
🔹 Context matters — the potential consequences of misdiagnosis and therapeutic interventions also need to be considered
🔹 Optimization — dose and image quality should be optimized for the patient, clinical task, procedure, and equipment
🔹 Clear communication — risk information should be balanced, contextualized, and understandable
🔹 Lifetime Attributable Risk (LAR) — how radiation risk metrics can complement traditional dosimetric quantities

The article also looks at the implementation of LAR calculations in DOSE by Qaelum and compares estimates derived from effective dose and organ dose across 19,248 spiral CT acquisitions.

📊 We summarized the key concepts in the infographic below.

👉 Read the full article:
https://qaelum.com/news/news/risk-communication-in-medical-imaging-key-issues-and-current-approaches

👉 Learn more about DOSE by Qaelum:
https://qaelum.com/solutions/dose

Qaelum | Transforming imaging data into actionable insights.

Join Qaelum at   in Valencia!Niki Fitousi, PhD, Head of Research & Development from Qaelum, will present research conduc...
24/09/2026

Join Qaelum at in Valencia!
Niki Fitousi, PhD, Head of Research & Development from Qaelum, will present research conducted in collaboration with Universitätsklinikum Bonn:
“Assessing dose and noise performance in a routine abdomen and pelvis CT protocol on new technology scanners”

📅 25 September 2026
🕔 Session time: 17:00–18:30
📍 Scientific Session Medical Imaging II | Valencia, Spain

Authors: Niki Fitousi, Laura Garajová, Anna Romanyukha and Alois Sprinkart.

Join the session to learn more about this collaborative research. We look forward to connecting with the medical physics community in Valencia!
https://qaelum.com/events/upcoming-events/qaelum-at-ecmp-2026-assessing-dose-and-noise-performance-in-ct

Adresse

Kolonel Begaultlaan 1B
Wilsele
3012

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque QAELUM publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager

Services Informatiques Et électroniques à proximité